These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8833970)

  • 21. Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms.
    Raj TJ; Bharati CH; Rao KR; Rao PS; Narayan GK; Parikh K
    J Pharm Biomed Anal; 2007 Mar; 43(4):1470-5. PubMed ID: 17125952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
    Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
    J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impurity profile tracking for active pharmaceutical ingredients: case reports.
    Zhou L; Mao B; Reamer R; Novak T; Ge Z
    J Pharm Biomed Anal; 2007 Jun; 44(2):421-9. PubMed ID: 17142001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of impurity profiles of drugs and related materials Part 15. Identification of minor impurities in cimetidine.
    Halmos Z; Szántay C; Brlik J; Csehi A; Varga K; Horváth P; Kislaki M; Domány G; Nemes A; Görög S
    J Pharm Biomed Anal; 1996 Oct; 15(1):1-5. PubMed ID: 8895070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical and analytical characterization of related organic impurities in drugs.
    Görög S
    Anal Bioanal Chem; 2003 Nov; 377(5):852-62. PubMed ID: 12937879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
    Li M; Lin M; Rustum A
    J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Are ultraviolet and visible spectroscopy and spectrophotometry obsolete methods in pharmaceutical analysis?].
    Görög S; Babják M; Gazdag M; Horváth P; Osztheimer E; Rényei M; Varga K
    Acta Pharm Hung; 1999 Apr; 69(2):60-8. PubMed ID: 10389299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification, isolation, characterization and response factor determination of process-related impurity in meprobamate drug substance.
    Karthikeyan K; Arularasu GT; Murali V; Pillai KC
    J Pharm Biomed Anal; 2011 Jan; 54(1):208-12. PubMed ID: 20727702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LC determination of glimepiride and its related impurities.
    Khan MA; Sinha S; Vartak S; Bhartiya A; Kumar S
    J Pharm Biomed Anal; 2005 Oct; 39(5):928-43. PubMed ID: 16040224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic toxicological analysis by high-performance liquid chromatography with diode array detection (HPLC-DAD).
    Pragst F; Herzler M; Erxleben BT
    Clin Chem Lab Med; 2004; 42(11):1325-40. PubMed ID: 15576293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of steroids Part 50. Derivatization of ketosteroids for their separation and determination by capillary electrophoresis.
    Görög S; Gazdag M; Kemenes-Bakos P
    J Pharm Biomed Anal; 1996 Jun; 14(8-10):1115-24. PubMed ID: 8818023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On-line diode array UV-visible spectrometry in screening for drugs and drug metabolites by high-performance liquid chromatography.
    Overzet F; Rurak A; van der Voet H; Drenth BF; Ghijsen RT; de Zeeuw RA
    J Chromatogr; 1983 Sep; 267(2):329-45. PubMed ID: 6630371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of pharmaceutical impurities using multi-heartcutting 2D LC coupled with UV-charged aerosol MS detection.
    Zhang K; Li Y; Tsang M; Chetwyn NP
    J Sep Sci; 2013 Sep; 36(18):2986-92. PubMed ID: 23821312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple and sensitive method to analyze genotoxic impurity hydrazine in pharmaceutical materials.
    Wang J; Yang S; Zhang K
    J Pharm Biomed Anal; 2016 Jul; 126():141-7. PubMed ID: 27208624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of impurity profiles of drugs and related materials. Part 9: HPLC investigation of flumecinol.
    Görög S; Herényi B; Rényei M
    J Pharm Biomed Anal; 1992; 10(10-12):831-5. PubMed ID: 1298390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic approach to development of liquid chromatographic impurity methods for pharmaceutical analysis.
    Stafford JD; Maloney TD; Myers DP; Cintron JM; Castle BC
    J Pharm Biomed Anal; 2011 Sep; 56(2):280-92. PubMed ID: 21665403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug impurity profiling strategies.
    Görög S; Babják M; Balogh G; Brlik J; Csehi A; Dravecz F; Gasdag M; Horváth P; Laukó A; Varga K
    Talanta; 1997 Sep; 44(9):1517-26. PubMed ID: 18966892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impurity profile study of dutasteride.
    Satyanarayana K; Srinivas K; Himabindu V; Mahesh Reddy G
    Pharmazie; 2007 Oct; 62(10):743-6. PubMed ID: 18236777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On-line screening for drug metabolites by high-performance liquid chromatography with a diode array UV detector.
    Zech K; Huber R; Elgass H
    J Chromatogr; 1983 Dec; 282():161-7. PubMed ID: 6674313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis and evaluation of the impurity of felodipine and its tablets].
    Zhang N; Yu LJ; Li J; Tong JW; Meng J; Zhang QM; Shi YQ
    Yao Xue Xue Bao; 2012 Feb; 47(2):223-8. PubMed ID: 22512035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.